Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bilateral macular edema secondary to nab-paclitaxel therapy for breast cancer.

International journal of ophthalmology·2024
Same author

Senescent endothelial cells: a potential target for diabetic retinopathy.

Angiogenesis·2024
Same author

Microglial Galectin3 enhances endothelial metabolism and promotes pathological angiogenesis via Notch inhibition by competitively binding to Jag1.

Cell death & disease·2023
Same author

The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: A meta-analysis of observational studies.

Frontiers in molecular biosciences·2022
Same author

Associations between psycho-behavioral risk factors and diabetic retinopathy: NHANES (2005-2018).

Frontiers in public health·2022
Same author

The Significance of the Ocular Adverse Effect Induced by Systemic Taxane Application.

Frontiers in bioscience (Landmark edition)·2022

Related Experiment Video

Updated: Nov 11, 2025

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
11:49

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

17.2K

PFKFB3: A Potential Key to Ocular Angiogenesis.

Zi-Yi Zhou1, Lin Wang2, Yu-Sheng Wang1

  • 1Department of Ophthalmology, Xijing Hospital, Eye Institute of Chinese PLA, Fourth Military Medical University, Xi'an, China.

Frontiers in Cell and Developmental Biology
|March 29, 2021
PubMed
Summary

Targeting endothelial glycolysis, particularly the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, offers a novel approach for treating pathological ocular angiogenesis, addressing limitations of current anti-VEGF therapies.

Keywords:
PFKFB3endothelial cellendothelial metabolismglycolysisocular angiogenesis

More Related Videos

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
06:10

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

Published on: August 6, 2020

6.0K
Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
06:51

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

4.8K

Related Experiment Videos

Last Updated: Nov 11, 2025

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
11:49

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

17.2K
An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
06:10

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

Published on: August 6, 2020

6.0K
Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
06:51

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

4.8K

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Biochemistry

Background:

  • Current treatments for pathological ocular angiogenesis primarily use anti-VEGF therapies, which show limited efficacy and side effects.
  • Endothelial cell metabolism, specifically glycolysis, is emerging as a critical factor in neovascularization.
  • Dysregulated glycolysis in endothelial cells contributes to pathological angiogenesis.

Purpose of the Study:

  • To review the role of endothelial glycolysis in pathological ocular angiogenesis.
  • To explore the potential of targeting endothelial glycolysis as a novel therapeutic strategy.
  • To discuss the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a specific target.

Main Methods:

  • Literature review of studies on endothelial glycolysis and ocular angiogenesis.
  • Analysis of the biochemical pathways involved in endothelial glycolysis.
  • Evaluation of existing and potential therapeutic interventions targeting endothelial glycolysis.

Main Results:

  • Endothelial glycolysis plays a significant role in the sprouting and proliferation of new blood vessels in ocular diseases.
  • Targeting key enzymes in the glycolytic pathway, such as 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, can inhibit pathological angiogenesis.
  • Modulating endothelial glycolysis presents a promising alternative or adjunct to anti-VEGF treatments.

Conclusions:

  • Endothelial glycolysis is a viable and promising therapeutic target for ocular pathological angiogenesis.
  • Regulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase offers a specific mechanism to control pathological neovascularization.
  • Further research into targeting endothelial metabolism could lead to more effective treatments for vision-threatening angiogenesis.